Suchergebnisse - "Cano, Juana María"

PubPharm (40)

1

State of the scientific evidence and recommendations for the management of older patients with gastric cancer

enthalten in: Journal of geriatric oncology | 2024

von Paredero-Pérez, I. | Jimenez-Fonseca, P. | Cano, J. | +6

2

Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

enthalten in: JAMA network open | 2024

von Torres-Esquius, S. | Llop-Guevara, A. | Gutiérrez-Enríquez, S. | +24

3

Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Arias-Martinez, A. | Martínez de Castro, E. | Gallego, J. | +28

4

Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma : data from the Spanish AGAMENON-SEOM registry

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Pérez-Wert, P. | Custodio, A. | Jimenez-Fonseca, P. | +24

5

Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain

enthalten in: Therapeutic advances in medical oncology | 2024

von Carrillo-García, J. | Lacerenza, S. | Hindi, N. | +13

6

Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry

enthalten in: Gastric Cancer | 2023

von Pérez-Wert, P. | Custodio, A. | Jimenez-Fonseca, P. | +23

7

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2023

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

8

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations : data from the SEPTRALU study

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Mitjavila, M. | Jimenez-Fonseca, P. | Belló, P. | +21

9

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Mitjavila, M. | Jimenez-Fonseca, P. | Belló, P. | +21

10

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

enthalten in: European journal of nuclear medicine & molecular imaging | 2023

von Mitjavila, M. | Jimenez-Fonseca, P. | Belló, P. | +21